Philip Astley-Sparke

Insider Reports History

Location
C/O Biovex Group, Inc., 34 Commerce Way, Woburn, MA
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Astley-Sparke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Director Common Stock 1.41M $11.3M $8.06 May 20, 2025 Direct
enGene Holdings Inc. Director Common Shares 20K $57.6K $2.88 Jul 8, 2025 Direct
enGene Holdings Inc. Director Stock Option (Right to Buy) 45K Jul 8, 2025 Direct

Insider Reports Filed by Philip Astley-Sparke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENGN enGene Holdings Inc. Jul 8, 2025 1 $0 4 Jul 10, 2025 Director
ENGN enGene Holdings Inc. Jul 8, 2025 0 $0 3 Jul 8, 2025 Director
REPL Replimune Group, Inc. May 20, 2025 1 -$260K 4 May 22, 2025 Director
REPL Replimune Group, Inc. Aug 30, 2024 1 $0 4 Aug 30, 2024 Executive Chairman, Director
REPL Replimune Group, Inc. May 16, 2024 1 -$245K 4 May 20, 2024 Executive Chairman, Director
REPL Replimune Group, Inc. May 16, 2023 1 -$323K 4 May 18, 2023 Chief Executive Officer, Director
REPL Replimune Group, Inc. Apr 1, 2023 2 $0 4 Apr 4, 2023 Chief Executive Officer, Director
REPL Replimune Group, Inc. May 16, 2022 1 -$141K 4 May 18, 2022 Chief Executive Officer, Director
REPL Replimune Group, Inc. Apr 1, 2022 2 $0 4 Apr 5, 2022 Chief Executive Officer, Director
FRBN Forbion European Acquisition Corp. Dec 9, 2021 0 $0 3 Dec 9, 2021 Director